Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 638 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases MOST POPULAR FDA Approves Durvalumab for Resectable Gastric or Gastro-Oesophageal Junction Adenocarcinoma December 5, 2025 Physical Activity May Lessen the Effects of Chemobrain, Study Finds August 26, 2021 Monoclonal Antibodies May Lower Recurrence Risk for Some Early Stage Breast... February 2, 2022 Moving target – retrotransposable elements and cancer July 11, 2023 Load more HOT NEWS Wine Racks and the Mystery of Survival Surgery for Recurrent Ovarian Cancer Does Not Improve Survival FDA Approves Teclistamab-cqyv for Relapsed or Refractory Multiple Myeloma Efficacy of ICI Combined with Chemotherapy in Patients with Advanced Penile...
